Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
Condition(s):Contrast Induced NephropathyLast Updated:October 4, 2019Withdrawn
Hide Studies Not Open or Pending
Condition(s):Contrast Induced NephropathyLast Updated:October 4, 2019Withdrawn
Condition(s):Contrast-Induced NephropathyLast Updated:April 15, 2014Completed
Condition(s):Contrast Induced NephropathyLast Updated:May 8, 2012Completed
Condition(s):Contrast-Induced NephropathyLast Updated:March 17, 2014Unknown status
Condition(s):Contrast Induced NephropathyLast Updated:February 16, 2023Active, not recruiting
Condition(s):Myocardial Infarction; Contrast-induced NephropathyLast Updated:January 4, 2023Completed
Condition(s):Contrast Induced NephropathyLast Updated:September 5, 2008Completed
Condition(s):Contrast Induced NephropathyLast Updated:April 20, 2016Withdrawn
Condition(s):Contrast-induced Nephropathy; Acute Kidney Injury; Acute Coronary SyndromeLast Updated:December 16, 2022Completed
Condition(s):Contrast Induced NephropathyLast Updated:August 2, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.